Evidence map›Paper›PMID 42196178›Full record

ReviewInternational journal of molecular sciences2026

Ergosterol: Biological Activities, Mechanistic Evidence, Pharmacokinetic Barriers, and Delivery Strategies.

Mingkai Yao, Cui Li, Mengya Dang, Na Zhang, Xiaoyun Yang, Yuping Wang, Mengru Cai, Dong Bai

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mingkai YaoInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0009-0007-9180-6788
Cui LiInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Mengya DangInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Na ZhangInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Xiaoyun YangInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Yuping WangInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Mengru CaiInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Dong BaiInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Funding

China Academy of Chinese Medical Sciences CI2021A0O108China Academy of Chinese Medical Sciences CYZ-202529China Academy of Chinese Medical Sciences KYG-202409the Fundamental Research Funds for the Central Public Welfare Research Institutes CYZ-202508the Fundamental Research Funds for the Central Public Welfare Research Institutes YZX-202419the Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ18-YQ-046
6 · The paper itself

Abstract

Ergosterol is a fungal sterol with broad pharmacological activities, including anticancer, anti-inflammatory, cholesterol- and uric acid-lowering effects, and serves as the precursor of vitamin D

Indexed as

ErgosterolAnimalsBiological AvailabilityDrug Delivery SystemsHumansSignal TransductionErgosterolbioactivitybioavailabilitydelivery systemsergosterolpharmacokinetics

Identifiers

PMID42196178
PMCPMC13207146

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.